ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

Bills To Lift $50 Cap On Mammography Will Be Introduced

February 10, 1989

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004